TREA

79402612 - CARSGEN

Follow

Information

  • Trademark
  • 79402612
  • Serial Number
    79402612
  • Filing Date
    April 09, 2024
    a year ago
  • Transaction Date
    April 05, 2025
    a month ago
  • Status Date
    April 04, 2025
    a month ago
  • Location Date
    April 04, 2025
    a month ago
  • Status Code
    645
  • Current Location
    TMO LAW OFFICE 115
    Employee Name
    MAHMOUDI, MARIAM
  • Attorney Docket Number
    Caihe-TM2
    Attorney Name
    Adam Bell
    Law Office Assigned Location Code
    M60
  • Owners
Information
Mark Drawing Code
5
Mark Identification
CARSGEN
Case File Statements
  • GS0051: Pharmaceutical preparations for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases ; drugs for medical purposes, namely, pharmaceutical preparations for treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases; biological preparations for medical purposes for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases; medicinal solutions for injection, namely, medicines for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases; biomedicine for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases; blood for medical purposes; pre-filled syringes for medical purposes filled with pharmaceutical preparations for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; pharmaceuticals for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases; biological tissue cultures for medical purposes; serotherapeutic medicines for the treatment of tumor or cancer, autoimmune diseases or disorders, inflammatory diseases, non-communicable diseases, infectious diseases, immune system related diseases and disorders, or blood diseases
  • GS0441: Medical screening; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; human tissue bank services; alternative medicine services; therapy services, namely, medical therapy, medicine therapy, immunotherapy, cell therapy, gene therapy, antibody therapy, antibody-drug conjugate therapy, radiation therapy, chemotherapy, or stem cell therapy; telemedicine services; health care; medical clinic services
  • GS0421: Scientific research; scientific laboratory services; research and development of new products for others; technical project studies, namely, conducting scientific feasibility studies; technological research in the field of pharmaceutical studies, biotechnology, medicine, immunotherapy; chemical research; chemistry services, namely, chemist services and chemistry consultation; chemical analysis; medical research; medical and scientific research, namely, conducting clinical trials for others; biological research
Case File Event Statements
  • 8/22/2024 - 9 months ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 8/23/2024 - 9 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/23/2024 - 9 months ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 10/22/2024 - 7 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/29/2024 - 6 months ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 10/22/2024 - 7 months ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/23/2024 - 7 months ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 10/29/2024 - 6 months ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 4/1/2025 - a month ago
    11 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 4/1/2025 - a month ago
    10 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 4/1/2025 - a month ago
    14 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 4/1/2025 - a month ago
    12 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 4/1/2025 - a month ago
    15 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 4/1/2025 - a month ago
    13 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 11/17/2024 - 6 months ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 4/2/2025 - a month ago
    16 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/2/2025 - a month ago
    18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/4/2025 - a month ago
    19 - FINAL REFUSAL WRITTEN Type: CNFR
  • 4/4/2025 - a month ago
    20 - FINAL REFUSAL E-MAILED Type: GNFR
  • 4/4/2025 - a month ago
    21 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 4/2/2025 - a month ago
    17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA